Registration, quality assurance and the shape of a medicines contract
A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programmes -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.
Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.
The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and programme funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.
This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.
Who buys pharmaceuticals in Norway?
GlobalGov holds 378 pharmaceuticals records from 111 distinct buying organisations in Norway. The most frequent publishers are Arbeids- Og Velferdsetaten (48 records); Sykehusinnkjøp HF (30 records); Sykehusinnkjøp Hf (21 records); EU Agency (13 records); Oslo kommune v/ Vann- og avløpsetaten (8 records); Forsvaret v/Forsvarets logistikkorganisasjon (7 records). Between them the 6 largest account for 34% of everything published, so buying here is spread across many separate authorities.
| Buying organisation | Records | Share |
|---|---|---|
| Arbeids- Og Velferdsetaten | 48 | 13% |
| Sykehusinnkjøp HF | 30 | 7.9% |
| Sykehusinnkjøp Hf | 21 | 5.6% |
| EU Agency | 13 | 3.4% |
| Oslo kommune v/ Vann- og avløpsetaten | 8 | 2.1% |
| Forsvaret v/Forsvarets logistikkorganisasjon | 7 | 1.9% |
What are pharmaceuticals contracts worth in Norway?
212 of the 378 records publish a contract value. The median is $2.1M and the largest single published value is $598.5M. By size, 1 under $100k, 64 between $100k and $1M, 83 between $1M and $10M, 64 above $10M. The remaining 166 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.
| Contract size | Records | Share of priced |
|---|---|---|
| under $100k | 1 | 0.5% |
| between $100k and $1M | 64 | 30% |
| between $1M and $10M | 83 | 39% |
| above $10M | 64 | 30% |
How long do bidders get to respond to pharmaceuticals tenders in Norway?
Across the 73 Norway pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 36 days. A quarter of them allowed 32 days or fewer and a quarter stayed open for more than 47. Short turnarounds are the exception rather than the rule here: only 1 (1.4%) closed within a fortnight of being published.
How often are pharmaceuticals tenders published in Norway?
Norway publishes about 7 notices a month in this category, 86 in the last twelve months. That is 177% more than the 31 published in the twelve months before that. Over the last three years there were 171, spread across 55 separate months of activity since 30 September 2003. May is historically the busiest month. No new notice has been published in this category since 19 June 2026, 104 days ago, so treat the figures above as a record of the market rather than as this week's pipeline.
How does Norway compare with other pharmaceuticals markets?
Among the 39 countries where GlobalGov holds a comparable pharmaceuticals market, Norway ranks 16th by number of records. The largest is Germany (4,115 records against 378 here). Within Norway itself, pharmaceuticals is the 22nd largest of the 61 procurement categories tracked here.
Where do the Norway pharmaceuticals records on this page come from?
These 378 records are collected from 2 official sources: TED (334), Doffin (44). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-01.
Most recent Pharmaceuticals tenders in Norway
None of these are open for bids now — they are the most recent records GlobalGov holds for this market, kept here so the shape of a typical pharmaceuticals notice in Norway is visible. Set an alert to be told when the next one opens.
Norway – Laboratory reagents – Infection immunological analyses, St. Olavs Hospital.
Norway – Guidance and counselling services – Procurement of studies with support to Nav Troms and Finnmark
Norway – Welfare services not delivered through residential institutions – Stage 1: Competition for the procurement of environment therapeutic relief measures and respite care offers for children and youths in Bergen municipality.
Norway – Social work and related services – Qualification - User managed personal assistant (BPA) for municipalities in the Kongsvinger region 2025 - 2029.
Norway – Social work services with accommodation – Welfare services and housing with 24 hour staffing
Other procurement categories in Norway
Medical EquipmentSoftware DevelopmentCivil ConstructionBuilding ConstructionWaste ManagementManagement ConsultingVehicles and FleetVehicle MaintenanceArchitecture and EngineeringMaintenance & RepairOffice FurnitureGround TransportRoad & InfrastructureLaboratory EquipmentIT ConsultingHospital ConstructionIct EquipmentRoads and Highways InfrastructureBuilding MaterialsScientific ResearchConsultingFood Aid and NutritionHealthcare ServicesUniforms ClothingPrinting PublishingTransportationResearch & DevelopmentFreight and LogisticsTraining & EducationCommunications PrTelecommunicationsTraining and Capacity BuildingSecurity ServicesFacilities and CleaningEnergyFinancial AdvisoryFuel SupplyCommunity DevelopmentStaffing AugmentationCatering ServicesAudit and AccountingAgricultural EquipmentEnvironmental ServicesMail CourierOil Gas UpstreamFinancial ServicesRenovation RehabilitationEvent ManagementWarehousingMilitary LogisticsCybersecurityLegal ServicesWeapons SystemsMonitoring EvaluationDatabase ManagementSchools and UniversitiesSanitation SewerageResearch and StudiesCurriculum DevelopmentWater Supply Projects
Pharmaceuticals procurement in other markets
GermanyUnited StatesItalyPolandFranceSpainRomaniaUnited KingdomSwedenCroatiaCzech RepublicNetherlands
Never Miss a Norway Government Contract
Finding Norway tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new pharmaceuticals opportunity is published there.
Start Free Trial